AbbVie (ABBV) Long-Term Debt Repayments (2015 - 2026)
AbbVie (ABBV) recorded Long-Term Debt Repayments of $2 billion in Q2 2026, down 46.7% from $3.75 billion a year earlier.
Powered by 
Analysis
AbbVie (ABBV) Long-Term Debt Repayments (2015 - 2026) Analysis & Trends
On a TTM basis, AbbVie's Long-Term Debt Repayments came in at $2.02 billion as of Jun 30, 2026, down 84.4% year-over-year; for FY2025, it came in at $6.8 billion, down 29.3% from FY2024.
- Annual Long-Term Debt Repayments has a five-year compound annual growth rate of 3.6% (FY2020 to FY2025).
- Across earlier years, Long-Term Debt Repayments came in at $9.61 billion in FY2024 (+131.7%), $4.15 billion in FY2023 (-71.3%), $14.43 billion in FY2022 (+53.3%) and $9.41 billion in FY2021 (+65.7%).
- Quarterly Long-Term Debt Repayments has ranged from $2 million in Q2 2022 to $6.85 billion in Q4 2022 over the past five years.
- On a year-over-year basis, Long-Term Debt Repayments rose in two of the last five quarters, with an average decline of 2.2%.
- Peak year-over-year performance for Long-Term Debt Repayments in the last five years was growth of 238.1% in Q3 2021, against a decline of 99.9% in Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 873.00 Mn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 1.00 Mn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 2.00 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 5.00 Mn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 20.00 Mn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 2.46 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 17.00 Mn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | - |
| 10 | Vertex Pharmaceuticals | 127.25 Bn | 99.26 Bn | 2.84 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.00 Bn |
| Dec 31, 2025 | 8.00 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 3.75 Bn |
| Mar 31, 2025 | 3.03 Bn |
| Dec 31, 2024 | 5.76 Bn |
| Sep 30, 2024 | 403.00 Mn |
| Jun 30, 2024 | 3.35 Bn |
| Mar 31, 2024 | 103.00 Mn |
| Dec 31, 2023 | 1.79 Bn |
| Sep 30, 2023 | 2.00 Mn |
| Jun 30, 2023 | 1.00 Bn |
| Mar 31, 2023 | 1.35 Bn |
| Dec 31, 2022 | 6.85 Bn |
| Sep 30, 2022 | 2.70 Bn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 4.88 Bn |
| Dec 31, 2021 | 3.75 Bn |
| Sep 30, 2021 | 2.20 Bn |
| Jun 30, 2021 | 3.46 Bn |
API Access
AbbVie Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();